Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study (original) (raw)
Fig 2
Temporal trends in antithrombotic treatment in patients with atrial fibrillation undergoing percutaneous coronary intervention.
The 10-year trends in prescription patterns of antithrombotic therapy among patients with AF undergoing PCI are presented among the total population (a), those at high risk of stroke (CHA2DS2-VASc score ≥2) (b), and both male (c) and female (d) patients. Patients who received SAPT, OAC monotherapy, and dual therapy with OAC and SAPT were grouped into other types of antithrombotic therapy, as the prescription rates were very low. AF, atrial fibrillation; PCI, percutaneous coronary intervention; DAPT, dual antiplatelet therapy; NOAC, non-vitamin K antagonist oral anticoagulants.